logo-loader

Black Swan completes share rollback

Published: 08:31 07 Feb 2025 EST

Black Swan Graphene (TSX-V:SWAN) announced that it has consolidated its capital on a one-for-eight basis.

Starting Monday, February 10, the company’s shares will commence trading on the TSX Venture Exchange on a consolidated basis.

Immunic Therapeutics reaches major milestone with completion of ENSURE Trial...

Immunic Therapeutics Chief Medical Officer Dr Andreas Muehler joined Steve Darling from Proactive to announce two major developments for the company’s lead drug candidate, vidofludimus calcium (IMU-838)—a nuclear receptor-related 1 (Nurr1) activator currently being investigated for the treatment...

14 hours, 52 minutes ago
OSZAR »